title: Use of first-line treatment for Neisseria gonorrhoeae after treatment guideline changes.
abstract: After 2 notices with treatment recommendation changes for Neisseria gonorrhoeae, the Philadelphia Department of Public Health documented medical therapy for 92% (3279/3551) of cases; 3001 (92%) received a recommended therapy. Nonrecommended therapies were documented in 8% of cases. Providers diagnosing 2 or less N. gonorrhoeae cases were more likely to use nonrecommended therapy.
authors: From the *Division of Disease Control, Philadelphia Department of Public Health, Philadelphia, PA; and †Division of STD Prevention, US. Centers for Disease Control and Prevention, Atlanta, GA.
authors: Greta
authors: G
authors: Anschuetz
authors: Lenore
authors: L
authors: Asbel
authors: Melinda E
authors: ME
authors: Salmon
authors: Caroline C
authors: CC
authors: Johnson
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D004352:Drug Resistance, Microbial / Q000187:drug effects*; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy*; D006801:Humans; D008297:Male; D009344:Neisseria gonorrhoeae / Q000472:pathogenicity*; D017410:Practice Guidelines as Topic; D011634:Public Health; D018571:Sentinel Surveillance
chemical_list: D000900:Anti-Bacterial Agents